Southwest to Pour $...
Health Care: Drugs
Johnson & Johnson (JNJ: NYSE)
$63.12 0.46 | 0.73%
05/24/12 - 03:59 PM ET
8.52M / 11.18M
Vol / Avg. Vol:62.89 / 62.66
Open / Prev. Close:62.80 - 63.34
Today's Range:59.08 - 68.05
52 Wk Range:-3.52%
Performance YTD:TheStreet Rating:
Portfolios with JNJ
- Portfolio NameUser Type
- Contributor22 Biopharma Stocks With Br...
- UserJMC Portfolio
- ProRay Dalio - Bridgewater Ass...
- ProWarren Buffett
- Userbasket
- UserJFleckensteins favorite picks
- ContributorDividend Stocks for the Wee...
- UserJimboPhi
- UserBen's Growth Dividend Stocks
- UserLRJ HOLDINGS
Latest JNJ Headlines from TheStreet
- Dow Component Johnson & Johnson (JNJ) To Go Ex-dividend Tomorrow 05.23.12 | 11:05 am
- Ex-Dividend Stocks: Johnson & Johnson, McGraw-Hill 05.23.12 | 06:05 am
- Pfizer, Glaxo, J&J Grab ASCO Spotlight 05.16.12 | 06:05 pm
- The Makeover Avon Needs After Coty Breakup 05.15.12 | 12:05 pm
- Johnson & Johnson (JNJ): Today's Featured Drugs Loser 05.14.12 | 04:05 pm
- Is Europe A Safe Place To Buy? Not Exactly 05.13.12 | 01:05 pm
- Johnson & Johnson Remains Too Big to Succeed 05.10.12 | 11:05 am
- Dow Today: Johnson & Johnson (JNJ) Leads The Day Higher, International Business Machines (IBM) Lags 05.08.12 | 03:05 pm
- Vertex Is the Next Gilead Sciences or Alexion 05.07.12 | 11:05 am
- 7 Dividend Stocks You Can't Ignore Right Now 05.07.12 | 07:05 am
Press Releases for JNJ
- Study Reports Catheter Ablation Superior To Drug Therapy As First-Line Treatment For Atrial Fibrillation - Business Wire 05.11.12 | 08:05 am
- Biosense Webster Announces Launch Of The THERMOCOOL® SF NAV Catheter With Curve Visualization - Business Wire 05.10.12 | 07:05 am
- Leading Authority On Eye Allergies Shares Tips, Offers Advice For Eye Allergy Sufferers On New Edition Of Healthy Vision⢠With Dr. Val Jones - PR Newswire 05.08.12 | 07:05 am
- Johnson & Johnson Holds 2012 Annual Meeting Of Shareholders - PR Newswire 04.26.12 | 10:04 am
- Johnson & Johnson Announces Dividend Increase Of 7.0% - PR Newswire 04.26.12 | 10:04 am
- Johnson & Johnson To Host Analyst Conference Call On First-Quarter Results - PR Newswire 04.10.12 | 12:04 pm
- Johnson & Johnson Announces Resignation Of Sheri S. McCoy - PR Newswire 04.09.12 | 07:04 am
- New Edition Of Healthy Vision⢠With Dr. Val Jones Kicks Off Sports Eye Safety Month With Information And Advice On Eye Protection And Protective Eyewear - PR Newswire 03.28.12 | 07:03 am
- XARELTO® (rivaroxaban) Demonstrates Comparable Efficacy To Standard Of Care For The Treatment And Secondary Prevention Of Venous Blood Clots In Patients With Symptomatic Pulmonary Embolism In Pivotal Phase 3 Study - PR Newswire 03.26.12 | 09:03 am
- The Ethicon Endo-Surgery Generator (Photo: Business Wire) - Business Wire 03.23.12 | 01:03 pm
Partner Headlines for JNJ
- Analyst Alerts: Occidental, Pandora, Xueda Education, J&J, SAIC May 24th - Wall St. Cheat Sheet 05.24.12 | 10:05 am
- AT&T and 2 Dow 30 Stocks Investors are Watching - Wall St. Cheat Sheet 05.24.12 | 02:05 am
- Zacks' Voice of the People highlights opportunities with Johnson & Johnson, Disney, Abbott Labs and Church & Dwight - Press Releases - Zacks 05.23.12 | 09:05 am
- Dow Movers: Procter & Gamble Getting Green, McDonald's Japan Problem - Wall St. Cheat Sheet 05.23.12 | 03:05 am
- Health Care SPDR In Focus Ahead Of Obamacare Decision - Benzinga 05.22.12 | 12:05 pm
- Medgenics Moving In Record Time - Seeking Alpha 05.21.12 | 09:05 am
- My Mad Method: Breaking Ties, What Next To Buy, And Why, Part 2 - Seeking Alpha 05.18.12 | 09:05 am
- The Zacks Analyst Blog Highlights: Covidien, General Electrical, Becton, Dickinson and Company, Johnson and Johnson and CR Bard - Press Releases - Zacks 05.14.12 | 09:05 am
- Generics Drive Dr. Reddy's - Analyst Blog - Zacks 05.14.12 | 09:05 am
- What Does Long Term Actually Mean? - Seeking Alpha 05.09.12 | 09:05 am
